News | January 06, 2022
Margins under pressure; domestic market growth to slow down: Nirmal Bang
A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies
A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies
Decisions reaffirm the ability of Biocon Biologics and Viatris to provide patient access to interchangeable Semglee
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
The approval of shelf life extension is based on the availability of additional stability data, which was submitted to the CDSCO
It is the first approved generic and is eligible for 180 days of Competitive Generic Therapy exclusivity
Gland Pharma believes that they are amongst one of the first to file for this product and may be eligible for 180 days of generic drug exclusivity
The ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
Nelarabine is in a class of medications called antimetabolites
Branded and unbranded versions of the first-ever interchangeable biosimilar in the U.S. provide more affordable options for the millions of Americans living with diabetes
The octocopter has successfully delivered 50 vials of Covid-19 vaccines along with syringes in a special container from Chandapura PHC to Haragadde PHC
Subscribe To Our Newsletter & Stay Updated
